Article
Case Report: Growth hormone deficiency and response to treatment in MIRAGE syndrome: expanding the endocrine phenotype.
Frontiers in endocrinology - 1 Jan 2026
Trapani Laura, Cognigni Marta, Maximova Natalia, Valencic Erica, Fachin Alice, Tamaro Gianluca, Tommasini Alberto, Tornese Gianluca
Abstract excerpt
Background: MIRAGE syndrome, a rare autosomal dominant disorder, is caused by heterozygous gain-of-function mutations in the SAMD9 gene. A key characteristic of MIRAGE syndrome is growth restriction. Although initially thought to stem mainly from prenatal and systemic factors, this growth restriction can also be a consequence of panhypopituitarism, leading to growth hormone deficiency (GHD). The use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
